Watch: Biotech Going Up Against Big Pharma

As co-founder, chairman & chief executive of Ocugen, Shankar Musunuri, is looking to bring eye disease products to the patients that big pharma’s drugs have left out. The Malvern, Penn.-based company has four compounds in its pipeline at various stages of development. It’s most advanced candidate, OCU300, is gearing up for Phase III trials in 2018. It’s second candidate, OCU310, combines brimonidine, a drug usually designed for patients with glaucoma, and a steroid. With some of Ocugen’s products, like it’s OCU100 compound designed to delay the progression of retinitis pigmentosa, there is no other drug currently on the market – so there’s no immediate competition. “The goal is to get something to the market to help patients as soon as possible because they don’t have anything today,”

Follow us on social media for the latest updates in B2B!

Image

Latest

AI data center
Power, Cooling, and Risk: What It Takes to Bring a 100MW AI Data Center Online
March 28, 2026

The industry knows how to build data centers. What it’s still figuring out is how to turn on AI factories at scale. With facilities now crossing 100 megawatts—far beyond the 5 to 10 megawatt norm of traditional builds—operators are no longer just validating equipment. They’re testing whether entire systems—power, cooling, controls, and the teams behind…

Read More
beauty
Building Beauty for Real Women: Why Brands Must Focus on Longevity, Not Hype
March 25, 2026

Walk into any beauty aisle—or scroll through your feed for five minutes—and it’s clear the industry is obsessed with what’s new. New formulas, new trends, new “rules.” But for many women, especially those who’ve been using makeup for decades, the question isn’t what’s new—it’s what actually works. And increasingly, the answer isn’t coming from the…

Read More
Physician
Fixing the Physician Experience: Why Advocacy Is Healthcare’s Next Frontier
March 25, 2026

Physician burnout has become a defining challenge in healthcare, with research showing that a substantial portion of clinicians—anywhere from roughly a quarter to over half—experience emotional exhaustion, driven more by systemic pressures like administrative burden and reduced autonomy than by individual resilience alone. As healthcare systems face growing staffing shortages and rising patient demand, the…

Read More
career
From Starting Over In A New Country To Reaching The C-Suite: A CFO’s Career Comeback
March 25, 2026

Global mobility is reshaping the modern workforce, with millions of professionals relocating each year in pursuit of opportunity, stability, or growth. Yet behind the headlines of talent migration lies a quieter, more difficult truth: restarting a career from scratch—even after years of success—is far more common than people expect. In fact, many skilled immigrants…

Read More